专题：Hematopoietic Stem Cell Transplantation

This cluster of papers focuses on the biology, regulation, and clinical applications of hematopoietic stem cells (HSCs) within the bone marrow niche. It covers topics such as HSC quiescence, stem cell aging, graft-versus-host disease, hematologic malignancies, and the role of mesenchymal stem cells in supporting HSC function. Additionally, it explores the mechanisms of stem cell mobilization and transplantation for therapeutic purposes.
最新文献
Phase 2 trial of cyclosporine-A, mycophenolate mofetil, and tocilizumab GVHD prophylaxis in cord blood transplantation

article Full Text OpenAlex

Comparison of outcomes between haploidentical and matched related donors for chronic myelomonocytic leukemia: A multicenter real‐world study

article Full Text OpenAlex

A Phase 2 Trial of CPX‐351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

article Full Text OpenAlex

Graft-Versus-Host Disease

book-chapter Full Text OpenAlex

Insights in Cellular and Molecular Signatures of the Small Intestinal Graft Posttransplantation: Successful, Recovered, and Rejected—A Case Series

article Full Text OpenAlex

Tumor-Infiltrating Clonal Hematopoiesis

article Full Text OpenAlex

Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1

article Full Text OpenAlex

Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors

article Full Text OpenAlex

Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesis

article Full Text OpenAlex

Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias

article Full Text OpenAlex

近5年高被引文献
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans

article Full Text OpenAlex 521 FWCI33.27

Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes

article Full Text OpenAlex 356 FWCI58.221

Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

article Full Text OpenAlex 350 FWCI54.469

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

article Full Text OpenAlex 341 FWCI32.653

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

article Full Text OpenAlex 272 FWCI122.003

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

article Full Text OpenAlex 263 FWCI61.306

The longitudinal dynamics and natural history of clonal haematopoiesis

article Full Text OpenAlex 248 FWCI56.644

Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling

article Full Text OpenAlex 241 FWCI17.036

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

article Full Text OpenAlex 213 FWCI31.804

The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

article Full Text OpenAlex 213 FWCI32.325